NCT00283036View on ClinicalTrials.gov

APROVE : Irbesartan in Hypertension

PHASE4CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

April 30, 2005

Conditions

Hypertension

Interventions

DRUG

Irbesartan

Trial Locations (1)

Unknown

Sanofi-Aventis, Algiers

Sponsors

Lead Sponsor

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Sanofi

INDUSTRY